Lyell Immunopharma, Inc. · NASDAQ:LYEL
Aguirre Jarrad Mattieu sold 422 Lyell Immunopharma, Inc. shares (Form 4)
Traded Oct 12, 2026 · Filed Oct 13, 2026
On Oct 12, 2026, Aguirre Jarrad Mattieu (Chief Medical Officer) sold 422 Lyell Immunopharma, Inc. shares at US$8.63 for US$3,642, leaving 19,857 shares. Filed Oct 13, 2026 (Form 4).
- Sold
- 422 shares
- Price
- US$8.63
- Value
- US$3,642
- Holding after
- 19,857 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | Common Stock | Sale | 422 | US$8.63 | 19,857 | Direct |